The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study
Abstract
The effect of vitamin K(2) (menatetrenone) on bone turnover was investigated in postmenopausal patients with osteoporosis. A 6-month open-label, randomized prospective study was conducted in 109 patients. The control group (n = 53) received calcium aspartate (133.8 mg of elemental calcium daily), while the menatetrenone group (n = 56) received 45 mg of menatetrenone daily for 6 months. Serum and urinary levels of bone turnover markers were monitored. The serum level of undercarboxylated osteocalcin (uc-OC) was significantly lower (P < 0.001) in the menatetrenone group than in the control group (at 1 month), while there was a higher level of osteocalcin containing gamma-carboxylated glutamic acid (Gla-OC) in the menatetrenone group than the control group (P = 0.018). Significant differences of uc-OC and Gla-OC between the two groups were observed from 1 month onward. In addition, a higher level of intact osteocalcin was found in the menatetrenone group compared with the control group after 6 months (P = 0.006). Assessment of bone resorption markers showed that menatetrenone therapy was associated with significantly higher urinary N-telopeptide of type I collagen (NTX) excretion compared with the control group after 6 months, while there was no significant difference of urinary deoxypyridinoline excretion between the two groups. In conclusion, one month of menatetrenone therapy enhanced the secretion and gamma-carboxylation of osteocalcin, while urinary NTX excretion was increa…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In another eight RCTs (not shown in table 3), the authors cited affected trial reports to draw attention to the disparities between their own findings and those reported.66–73”
From An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature (2019) · cites this paper as [73]
Citations
Cites
2 retracted
Ishida, Y., & Kawai, S. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.05.019 · Cited by 132
RetractedSato, Y., Honda, Y., Kuno, H., & Oizumi, K. (1998) · Bone · doi:10.1016/s8756-3282(98)00108-2 · Cited by 77 · cited 1×
“Previous studies have suggested that the urinary excretion of NTX and DPD is decreased by vitamin K2 treatment [36] or else shows no change [26, 27, 29], and there have been no previous reports about a positive effect of menatetrenone on bone resorption markers.”
ResultRetractedOsteoporosis Prevention, Diagnosis, and Therapy
NIH Consensus Development Panel on Osteoporosis Prevention, D. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.6.785 · Cited by 5,529
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Ettinger, B. (1999) · JAMA · doi:10.1001/jama.282.7.637 · Cited by 3,366 · cited 1×
“[7–12].”
Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,288
Mortality after all major types of osteoporotic fracture in men and women: an observational study
Center, J. R., Nguyen, T. V., Schneider, D., Sambrook, P. N., & Eisman, J. A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09075-8 · Cited by 1,926 · cited 1×
“Osteoporosis is characterized by a decrease of bone strength [1] and is a major problem for the elderly population, because it leads to an increase of fractures that impairs their quality of life [2–4] and increases mortality [5, 6].”
BackgroundEffect of Risedronate on the Risk of Hip Fracture in Elderly Women
McClung, M. R., Geusens, P., Miller, P. D., Zippel, H., Bensen, W. G., Roux, C., Adami, S., Fogelman, I., Diamond, T., Eastell, R., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440503 · Cited by 1,918
Increased bone formation in osteocalcin-deficient mice
Ducy, P., Desbois, C., Boyce, B., Pinero, G., Story, B., Dunstan, C., Smith, E., Bonadio, J., Goldstein, S., Gundberg, C., et al. (1996) · Nature · doi:10.1038/382448a0 · Cited by 1,725 · cited 1×
“Among several bone matrix proteins, osteocalcin probably has an important role in determining bone strength, because a rapid decrease of bone stiffness after oophorectomy has been observed in osteocalcin knockout mice [ 30 ].”
Background
Research works printed but not linked: 1
- Silverman SL, Minshall ME, Shen W, Harper KD, Xie S, Health-Related Quality of Life Subgroup of the Multiple Outcomes of Raloxifene Evaluation Study (2001) The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from Multiple Outcomes of Raloxifene Evaluation Study. Arthritis Rheum 44:2611–2619 · DOI · Paper page
Cited by
Molecular Mechanisms and Emerging Therapeutics for Osteoporosis
Noh, J.-Y., Yang, Y., & Jung, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207623 · Cited by 287
Villa, J. K. D., Diaz, M. A. N., Pizziolo, V. R., & Martino, H. S. D. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2016.1211616 · Cited by 151
Molecular-Based Treatment Strategies for Osteoporosis: A Literature Review
Ukon, Y., Makino, T., Kodama, J., Tsukazaki, H., Tateiwa, D., Yoshikawa, H., & Kaito, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102557 · Cited by 122
“Administration of menatetrenone would decrease the serum level of undercarboxylated osteocalcin [76].”
BackgroundVitamin K Nutrition and Bone Health
Tsugawa, N., & Shiraki, M. (2020) · Nutrients · doi:10.3390/nu12071909 · Cited by 131
“Vitamin K deficiency reduced cOC and increased ucOC, whereas vitamin K repletion recovered these abnormalities [42].”
BackgroundSelf-citationHuang, Z.-L., Wan, S., Lu, Y.-J., Ning, L., Liu, C., & Fan, S. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2989-6 · Cited by 116
Metadata
- Authors
- Shiraki, M., & Itabashi, A.
- Affiliations
- Research Institute and Practice for Involutional Diseases (JP)
- Corresponding author
- Shiraki, Masataka
- ORCID
- Shiraki, Masataka
- Venue
- Journal of Bone and Mineral Metabolism
- Published
- 2009-01-27
- Volume
- 27
- Issue
- 3
- Pages
- 333-340
- ISSN
- 0914-8779 (ISSN-L)
- 1435-5604
- OpenAlex
- W2087814901
- Cited by
- 40
- References
- 37
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2022: 3 · 2021: 1 · 2020: 3 · 2019: 5 · 2016: 2 · 2015: 3 · 2014: 4 · 2013: 4 · 2012: 1
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Bone and Mineral Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Vitamin K Research Studies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Keywords
- menatetrenone, vitamin K2, postmenopausal osteoporosis, osteocalcin, gamma-carboxylation, undercarboxylated osteocalcin, bone turnover, bone resorption, N-terminal telopeptide of type I collagen, deoxypyridinoline, calcium supplementation
- MeSH terms
- Aged, Calcium, Female, Hemostatics, Hormones, Humans, Lumbar Vertebrae, Protein Processing, Post-Translational, Time Factors, Biomarkers, Bone Density, Osteoporosis, Postmenopausal, Osteocalcin, Bone Remodeling, Treatment Outcome, Vitamin K 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study. https://app.cochat.ai/papers/10.1007/s00774-008-0034-6
- The paper
- Shiraki, M., & Itabashi, A. (2009). Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study. Journal of Bone and Mineral Metabolism. https://doi.org/10.1007/s00774-008-0034-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.